Home›Companies›Biotech & Pharma›Dimer Instruments

Dimer Instruments, Inc.

Dimer makes real-time molecular analysis instruments for pharmaceutical companies.

Updated Nov 10, 2026·Latest SEC filing Jul 24, 2026·Suggest an edit

About Dimer Instruments

Dimer Instruments is a private company based in Santa Barbara, California, incorporated in 2023 in Delaware. It has reported $11,000,000 raised in one offering on Form D since April 2024. Its chief executive is Stephen Minne.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 25, 2024Apr 29, 2024amended Jul 24, 2026$11,000,000fully sold1$11.0MEquityRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Dimer Instruments's Form D filed Jul 24, 2026.

Michael Larkin
Michael Larkin
Co-Founder and CTO, director
Stephen Minne
Stephen Minne
Co-Founder and CEO, director

Sources

  1. SECDIMER INSTRUMENTS, INC. Form D/A, filed Jul 23, 2025
  2. SECDIMER INSTRUMENTS, INC. Form D, filed Apr 29, 2024
  3. SECDIMER INSTRUMENTS, INC. filing history
  4. CompanyAbout Dimer Instruments